Author response for "Anagliptin twice‐daily regimen improves glycemic variability in subjects with type 2 diabetes: <scp>Double‐Blind</scp> , Randomized Controlled Trial"
crossref(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
crossref(2022)